OUR STORY
40 years of Swiss innovation in shock wave technology
Our goal: better therapies through new technology
As a reliable partner to physicians, we are shaping a piece of medical progress – in the service of new therapeutic procedures. The goal of our physicists and engineers is to further develop shock wave technology, to develop new device concepts and to open up new indications in close cooperation with leading medical institutes.
WHERE WE STARTED
How we became industry leaders
Foundation of the STORZ MEDICAL AG in Kreuzlingen, Switzerland. New ground is broken in medical technology. Shock wave therapy adds a non-invasive method to the choice of treatments.
Breakthrough in medical shock wave technology: Application for a patent for the electromagnetic cylindrical source. The prototype of the first modular lithotripter is produced.
Market launch of the first generation of lithotripters (MODULITH® SL10/SL20) with the patented electromagnetic STORZ MEDICAL cylindrical source, which is also equipped with X-ray localization in addition to in-line ultrasound localization.
.avif)
Market launch of the first lithotripter worldwide (MODULITH® SLX) equipped with in-line localization systems for both imaging modes (X-ray/ultrasound). The hollow geometry of the cylindrical source is used consistently to either X-ray through the source or work with an in-line ultrasound transducer.
For the first time a lithotripter (MINILITH® SL1) is used for the non-invasive treatment of salivary stones by Dr Wolfgang Kater in Frankfurt, Germany.
First treatment of spasms with the MINILITH® SL1 applied by Dr Henning Lohse-Busch in Bad Krozingen, Germany.
Prof Heinz Lohrer of the Institute for Sports Medicine Frankfurt Main (Sportmedizinisches Institut – SMI) is the first to apply the MINILITH® SL1 in the treatment of orthopaedic pain (ESWT) suffered by athletes at the Olympic Summer Games in Atlanta, USA.
Breakthrough in cardiology: For the first time a patient's heart (non-revascularizable angina pectoris) is treated with shock waves. The first CSWT (Cardiac Shock Wave Therapy) with the MODULITH® SLC is carried out by Prof Dr Raimund Erbel and Dr Guido Caspari in Essen, Germany. MODULITH SLC is not FDA approved and therefore not for sale in the U.S.
Presentation of the first interdisciplinary lithotripter (MODULITH® SLK) with patented, computer based navigation system (Lithotrack®): With this system it is for the first time possible to aim with a flexible therapy head at a position localized by X-ray with a C-arc.
The German physicians Dr Roman Strössenreuther (Moosburg-Freising), Dr Georg Popp (Augsburg), and Dr Werner Siems/Dr Reiner Brenke (Bad Ems) are the first to use the MINILITH® SL1 for the treatment of aesthetic indications (cellulite). In their studies they could prove a significant reduction of malondialdehyde and protein carbonyls (biomarkers for oxidative stress) in the plasma.
The dual focus is introduced to lithotripsy: The MODULITH® SLX-F2 is the first lithotripter with switchable focus size (precise or extended). First treatment of non-bacterial prostatitis/CPPS with the MINILITH® SL1 by Prof Arnulf Stenzl, Dr Reinhold Zimmermann and Dr Sven Lahme in Tübingen, Germany.
StorM-Touch with StorM-Base – the first fully integrated touch operated system for stone treatment with patient data management.
STORZ MEDICAL presents the V-ACTOR® vibration technology as an adjuvant treatment complementing shock wave therapy.
Launch of the new MODULITH® SLK »inline« – a cutting-edge, ergonomic design is combined with an optimal over-table and under-table positioning of the shock wave source.
STORZ MEDICAL combines shock wave therapy with ultrasound: the DUOLITH® SD1 »ultra« is the first modular shock wave therapy system worldwide with an integrated diagnostic ultrasound system.
STORZ MEDICAL presents the all-rounder in urology: the MODULITH® SLX-F2 »connect« combines a lithotripter and urological workstation with integrated X-ray flat panel detector.
STORZ MEDICAL launches the newest generation of radial pressure wave devices: the MASTERPULS® »ultra« line.
The new focused shock wave SEPIA® handpiece with integrated, clear display for rapid treatment navigation at reduced revision costs is introduced and successfully accepted by the market.
The MODULITH® SLK »intelect« can be used as a versatile lithotripter with a variety of urological workstations and C-arcs.
The MODULITH® SLX-F2 »FD21« with dynamic X-ray flat panel detector is the ideal stationary SWL system for customers with large numbers of patients.
STORZ MEDICAL develops a new radial pressure wave device, the MASTERPULS® ONE. It is characterised by its ease of use, compact design and the light SPARROW™ handpiece.
STORZ MEDICAL presents the NEUROLITH® for treatment of the central nervous system in patients with Alzheimer's disease using transcranial pulse stimulation (TPS®). Not available in the U.S.
The new MODULITH® SLC generation is designed for the treatment of ischaemic heart disease.
With the development of the MAGNETOLITH®, STORZ MEDICAL breaks new ground, extending its operations to the field of Extracorporeal Magnetotransduction Therapy (EMTT) for the treatment of disorders affecting the musculoskeletal system.
MEETING YOU WHERE YOU ARE
Worldwide Service and Cooperation
Medical specialists all over the world benefit from our experience using systems developed by STORZ MEDICAL AG. Based in Tägerwilen/Switzerland, the company operates around the globe through its branch offices and partners, making sure that qualified service personnel is always near at hand.You can also rely on our assistance and support in the development of new application methods. After all, it is your know-how and your ideas that pave the way for the further development of a leading technology.
Germany
STORZ MEDICAL Deutschland GmbH
Victor-Goerttler-Strasse 11
07745 Jena
Germany
Tel.: +49 (0)3641 53259-10
Fax: +49 (0)3641 53259-29
USA
STORZ MEDICAL America, Inc.
1000 Cobb Place Blvd.
Building 400, Suite 450
Kennesaw, GA 30144
United States of America
Tel.: +1 800-965-4846
Tel.: +1 678-354-6229
United Kingdom
STORZ MEDICAL (UK) Ltd
AMC House
Park Royal
12 Cumberland Avenue
NW10 7QL
London
United Kingdom
France
STORZ MEDICAL France SAS
21 Rue Eugène Sue
94700 Maisons Alfort
France
Tel.: +33 (0)1 43 75 75 20
Italy
STORZ MEDICAL Italia SRL
Via Salaria 1319
00138 Rome
Italy
Tel.:+39 06 88 88 174
Fax: +39 06 88 88 191
Spain
STORZ MEDICAL Italia – Sucursal en España
Carrer del Vallespir 19
Planta 5 Módulo 1.1
08173 Sant Cugat Del Vallés – Barcelona
Spain
Tel.: +34 (0)934 61 86 82
Japan
STORZ MEDICAL Japan Co., Ltd.
1-14-1, Owada, Ichikawa, Chiba 272-0025 Japan
Tel.: +81(0)47 369 6443
Fax: +81(0)47 369 6445
info@storzmedical.co.jp
Other Countries
Please contact STORZ MEDICAL headquarters for more information about country representatives.
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05
info@storzmedical.com
DOING OUR PART
Sustainability
At STORZ MEDICAL, sustainability is incredibly important to us and forms a central component of our corporate philosophy. This is reflected in the work we do on a day-to-day basis, which is based entirely on resource-saving processes, products and production sequences. It is also proven by our certification to the environmental management standard ISO 14001:2015.
The medical devices manufactured by STORZ MEDICAL are high quality and reusable. The use of durable materials means resource consumption and emissions can be reduced.
STORZ MEDICAL has had photovoltaic systems installed on its roofs since spring 2020. On sunny days, a large part of the electricity consumption is covered by renewable solar energy.
STORZ MEDICAL regularly sponsors local bee colonies. Bees are important contributors to a healthy ecosystem, which means they’re also important to us humans.
Bike 2 Work is a health and bike promotion campaign in Switzerland that encourages people to cycle to and from work instead of using CO2-emitting vehicles. STORZ MEDICAL has been participating in this campaign since 2018.
As of 2020, the offices and printers at the Tägerwilen site have been using 100% recycled paper. Recycled paper offers a whole host of environmental advantages over fresh fibre paper.
STORZ MEDICAL attaches great importance to the separation of different types of waste. Valuable recyclable materials can be reused if they are collected separately and properly disposed of.
System Certifications
Our management system is based on STORZ MEDICAL AG's principles governing quality, safety and environmental protection. It meets the requirements of internationally accepted standards and regulations and includes, inter alia, a certified quality management system in compliance with the EN ISO 13485:2016 and ISO 9001:2015 standards, as well as a certified environmental management system in accordance with the ISO 14001:2015 standard. The system complies with the requirements of Directive 93/42/EEC concerning medical devices (MDD), Annex II (excluding point 4 of Annex II), and of Taiwan's »Technical Cooperation Programme« (TCP) with certification to EN ISO 13485. Furthermore, additional standards and codes applicable within the scope of the Medical Device Single Audit Program (MDSAP) – e.g. the US FDA's »Quality System Regulation« (QSR) 21 CFR Part 820 – are also complied with.
Our products and services are designed to satisfy all the demands placed on them in relation to quality, safety and environmental protection. This is why product quality control is an essential part of our quality assurance activities, and why the focus of our environmental management measures is on environmental aspects along the life cycle of our products and services. Our goal is to manufacture products in line with market requirements using eco-friendly and resource-saving processes, and to conform to legal and social standards. For the benefit of customers, suppliers and ourselves we want, through continuity, to ensure lasting partnerships and, furthermore, to create long-term competitive advantages, by being a dependable partner in every respect – including quality, sustainability and care for the environment.
